Community › Food & Appetite

Four obesity stereotypes [some are GLP resistant]

8 replies7 peopleJan 28, 2026☆ Follow
Summary

What are the four obesity phenotypes and do GLP-1 drugs work differently across them?

The thread describes four observable obesity traits (Hungry Gut, Hungry Brain, Emotional Hunger, Slow Burn) that can overlap. One participant reports success with a GLP-1 agonist after a month. Another shares an AI summary on GLP-1 benefits for diabetic neuropathy that appears independent of weight loss. Several users criticize pasting raw AI text and suggest higher doses or other compounds for nerve-related benefits.

What this discussion establishesWhere people disagree

Whether long blocks of AI output should be posted at all

Still open

Which phenotypes respond best or worst to GLP-1 drugs

Nothing here is advice.

8 replies · 7 people
PlainPebble75archiveopening postJan 28

A mouth swab DNA check divides folks into four main obesity patterns based on visible traits, called Hungry Brain, Hungry Gut, Emotional Hunger, and Slow Burn, and someone can match more than one. Those with Hungry Brain stay wanting food even after taking in plenty of energy. Hungry Gut types feel satisfied yet get the urge again fast since the stomach clears quicker. Emotional Hunger means turning to eating from feelings instead of body signals. Slow Burn covers people whose system processes energy at a reduced pace, so holding steady weight feels tough. Which fits you? Emotional Hunger matches me completely.

LikeSame experienceReply
ClearKettle64archiveJan 28
↳ replying to @PlainPebble75 (opening post)

Curious if others have experimented with GLP-1 compounds and whether those delivered results.

LikeSame experienceReply
SlowHarbour49archiveJan 28

I've come across some research indicating these types of medications could help with nerve issues tied to diabetes by supporting better nerve structure and easing discomfort through protective and calming effects on the body. Findings point to gains in how signals travel along nerves, better scores on exams for nerve problems, and even changes in fiber appearance, including one report where most folks saw smaller nerve swelling after a few months. The benefits seem to happen apart from any slimming down, maybe by boosting certain cell pumps, cutting down swelling, and shielding cells from harm. Early signs also show drops in ongoing pain from the condition. Still, the data comes mostly from limited trials and lab work, so bigger studies over time would help pin down how well they work and the best way to use them. A few reports have flagged a possible link to a uncommon vision problem affecting the optic nerve, though results aren't consistent across all of them. Some newer combos are being looked at for even stronger results.

LikeSame experienceReply
PlainPebble75archiveJan 28
↳ replying to @ClearKettle64

Thirty plus days into using two milligrams of reta and the benefits are evident.

LikeSame experienceReply
QuietFenwick11archiveJan 28
↳ replying to @SlowHarbour49

I'd rather folks avoided dumping long blocks generated by artificial intelligence tools. Just offer a quick recap of the details uncovered instead.

LikeSame experienceReply
SlowHarbour49archiveJan 29

I regret having duplicated the material from right above this note.

LikeSame experienceReply
SteadyQuill55archiveJan 29
↳ replying to @SlowHarbour49

You're not alone in noticing. This habit keeps spreading and it's starting to grate on me. A couple times already this week on the job I've snapped back with something like "Quit dumping that artificial intelligence nonsense my way. If the answer needed the kind of insight and precision the fake version actually possessed, there'd be no reason for me to ask you at all." Before long the annoyance will hit everyone and we'll drop it entirely, but right now the pattern is still going strong.

LikeSame experienceReply
SharpCinder28archiveJan 29
↳ replying to @SlowHarbour49

I found the details on GLP agonists for neuropathy quite useful. Bigger dosages seem more effective, around eight milligrams for reta and ten for tirz. Past that point there might be smaller improvements overall regarding fat reduction, blood markers for metabolism, and similar perks. Cagri could offer support too, perhaps through separate mechanisms for nerve problems given that amylin receptors exist all over the nervous system. ARA-290 shows potential in repairing nerves according to studies in people, though it needs periodic breaks to sidestep possible unknown future issues. For extended messages one can enclose them in quote blocks like that to shorten their appearance on screen.

LikeSame experienceReply
WarmQuill37archiveJan 29
↳ replying to @PlainPebble75 (opening post)

Probably I'd classify as slow burn since my food intake stays pretty minimal. Sugar gives me trouble too, no matter how tiny the amount I consume.

LikeSame experienceReply

Add your experience

If you have tried it, this topic is still open. Sign in to reply — it takes a minute.

Sign inCreate an account
Four obesity stereotypes [some are GLP resistant] · ZyraTrack Community